PRINCETON, N.J., Feb. 3 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), a late-stage biotechnology company, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will give a corporate presentation at the 2010 BIO CEO & Investor Conference on Monday, February 8, at 4:00 PM Eastern Standard Time. The presentation will take place in the Park South Room at the Waldorf Astoria Hotel in New York City.
The Soligenix presentation will be webcast live and archived for later replay. To access the webcast, please visit the company's investor page at http://www.soligenix.com/invest_sec.shtml. A replay of the presentation will be archived for 90 days after the conference at the same location.
For more information about the 2010 BIO CEO & Investor Conference, please refer to the conference website at http://ceo.bio.org.
About Soligenix, Inc.
Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec® (oral beclomethasone dipropionate or BDP), is a potent, locally
|SOURCE Soligenix, Inc.|
Copyright©2010 PR Newswire.
All rights reserved